Description
Tesamorelin (10mg) by Katharos is manufactured using carefully controlled production processes and comprehensive quality standards to ensure exceptional consistency and reliability. Every batch is produced with precision and undergoes strict quality control before packaging, reflecting our commitment to delivering dependable products for research applications.
-
Tesamorelin is a synthetic 44-amino acid peptide sequence featuring a trans-3-hexenoic acid group attached to its N-terminus. This structural modification enhances its metabolic stability compared to native Growth Hormone-Releasing Factor (GRF).
-
Biochemical Mechanism: Tesamorelin binds specifically and selectively to GHRH receptors on pituitary somatotropes, stimulating the endogenous synthesis and pulsatile release of Growth Hormone (GH). The resulting elevation in GH stimulates the liver to produce Insulin-like Growth Factor 1 (IGF-1), which subsequently drives lipolysis—specifically targeting visceral adipose tissue dynamics through the breakdown of triglycerides.
-
Primary Research Applications: Visceral adiposity breakdown, hepatic lipid metabolism, pituitary somatotrope receptor kinetics, IGF-1 regulation, and carotid intima-media thickness modeling.
-
Notice: This product is strictly for research and laboratory educational purposes only and is not for human or animal use.
